Back to MW MARSHALL WACE, LLP

RIGLRIGL
6 quarters

Position history for MWMARSHALL WACE, LLP's holdings in RIGEL PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 367,393 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $14.4M as of 2026-Q2. The position was decreased (-38.6% shares). RIGL represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$14.4M

Current Shares

367,393

Total Value Change

+$10.6M

Total Shares Change

+155,645

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
367,393
-38.6%
$14.4M0.0%$39.12
0
2026-Q1
Decreased
598,378
-2.5%
$16.2M0.0%$33.02
0
2025-Q4
Increased
613,600
+2.0%
$26.3M0.0%$42.83
29
2025-Q3
Increased
601,333
+63.0%
$17M0.0%$28.75
41
2025-Q2
Increased
368,950
+74.2%
$6.9M0.0%$19.48
41
2025-Q1
New
211,748
-
$3.8M0.0%$17.88
37

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used